Think tank: Time to look beyond the gold standard in drug R&D Aug. 5, 2015 By Mark McCarty and Mari Serebrov No Comments As technology pulls medical innovation into the 21st century, the burnish may be wearing off randomized, controlled trials (RCTs), the FDA's longtime gold standard for developing new therapies. Read More
Inside the Beltway: BPC says 'pragmatic' studies plus RCTs needed for premarket applications Aug. 3, 2015 By Mark McCarty No Comments
Inside the beltway: Health care spending projection sure to trigger IPAB mandate July 31, 2015 By Mark McCarty No Comments
Inside the Beltway: App association chief says fix health IT payment or face economic disaster July 30, 2015 By Mark McCarty No Comments
Inside the Beltway: FDA to evaluate gadolinium in response to reports in literature July 29, 2015 By Mark McCarty No Comments
Inside the Beltway: AdvaMed questions notion that CMS can mandate participation in bundling July 28, 2015 By Mark McCarty No Comments
Inside the Beltway: Physician says payment penalty would increase PAD registry participation July 27, 2015 By Mark McCarty No Comments
Inside the Beltway: Medicare GDP forecast for 2089 assumes doctor practice costs will be ignored July 24, 2015 By Mark McCarty No Comments
Inside the Beltway: Harmonization of GCPs seen as sticking point for OUS trials draft July 23, 2015 By Mark McCarty No Comments